SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Neuromuscular Neurology Consultation — Wilma Mankiller

PatientWilma Mankiller
Date of birth1991-11-18
IdentifiersMRN HR-ML052-SYN; SSN (made up) 000-52-4183
Document date2026-03-23
AuthorMarcus Okafor-Delaney, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Woman of 34 with six weeks of fluctuating ptosis, diplopia and fatigable weakness of the arms, neck, chewing and voice, while recovering from a severe car crash last year: suspected generalized myasthenia gravis. Please confirm the diagnosis and advise on treatment, thymectomy and safety. [S]

Urgency: Urgent, within two weeks. [S]

Questions for the consultant:

History of Present Illness

Ms. Mankiller is seen at the request of Dr. Hawkfeather-Lindqvist for six weeks of drooping eyelids, double vision by evening, tiring of the arms when brushing her hair, a tired jaw while eating, and a nasal voice after long conversations. Pyridostigmine 30 mg three times daily has helped her eyelids for a few hours after each dose, with mild cramps. She has had no breathlessness, choking or weak cough. She is recovering from a head-on car crash last year with fractures of both legs, ribs and face and many operations, and walks with a cane on rough ground. She has hereditary polycystic kidney disease with normal kidney function. She works for the Cherokee Nation and lives in rural Adair County. She wants to understand each treatment before agreeing to it, and to have blood tests near home. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

8 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eatingOne tablet three times dailyOral route2026-03-09 to 2026-03-23completedS
Pyridostigmine bromide 60 mg oral tablet, one tablet four times daily while awake, 30 to 45 minutes before mealsOne tablet four times daily while awakeOral route2026-03-23 to 2026-10-12completedS
Prednisone 10 mg oral tablet, 10 mg each morning, rising by 10 mg each week to 40 mg each morning, then held at 40 mgOnce each morning; dose as directedOral route2026-03-23 to 2026-07-13completedS
Calcium carbonate 1250 mg (500 mg elemental calcium) oral tablet, one tablet daily with foodOne tablet daily with foodOral route2026-03-23activeS
Cholecalciferol (vitamin D3) 1000 units (0.025 mg) oral tablet, one tablet dailyOne tablet dailyOral route2026-03-23activeS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg painOne or two tablets up to three times daily as neededOral route2025-09-15activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspectedresolvedconfirmed H53.2S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.
Generalized myasthenia gravis, acetylcholine receptor antibody positive, MGFA class IIa, without thymoma; synthetic modern detail linked to her documented myasthenia gravis of 1980activeconfirmed G70.00S — Synthetic antibody level, electrodiagnosis, class and treatment; the diagnosis less than a year after the crash, and recovery with Cherokee medicine people, surgery and drug therapy, are documented (D).
Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be stagedactiveconfirmed Q61.2S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.
Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough groundactiveconfirmed Z87.81S — The crash, the operations and the injuries are documented (D); the current function is synthetic.
Long-term glucocorticoid therapy for myasthenia gravis, with monitoring of glucose, blood pressure, weight, bone health, mood, sleep, eyes and infectionactiveconfirmed Z79.52S — Synthetic treatment plan.

Physical Exam

Vital signs recorded on 2026-03-23; see the referring visit's Vital Signs section. [S]

SystemFinding
EyesLeft ptosis after 40 seconds of upgaze; diplopia on sustained right gaze; pupils normal
BulbarSpeech becomes nasal after counting to 40; jaw closure strong at rest
NeurologicalNeck flexion 4 of 5; deltoids fatigue after 45 seconds of arm abduction; reflexes and sensation normal
RespiratorySingle-breath count to 30; FVC 3.25 L; negative inspiratory force -68 cm H2O

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-23Acetylcholine receptor binding Ab [Moles/volume] in Serum6.8nmol/L0.02 nmol/L or less is negativeHighS
2026-03-23Forced vital capacity [Volume] Respiratory system3.25LLower limit of normal about 2.9 L for her age, sex and heightNormalS
2026-03-23Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S

Assessment

Data reviewed: Acetylcholine receptor binding antibodies 6.8 nmol/L (positive), drawn at the first visit; CT of the chest with contrast five days ago (residual thymic tissue for age, no thymoma, healed right rib fractures); kidney ultrasound five days ago (enlarged polycystic kidneys, height-adjusted total kidney volume 364 mL/m, Mayo Imaging Class 1B; small liver cysts); first-visit blood count, chemistry, TSH 1.9 mIU/L, hemoglobin A1c, urine albumin, FVC and negative inspiratory force; and repetitive nerve stimulation done today (3 Hz: 22 percent decrement in the nasalis, 18 percent in the trapezius, with partial repair after exercise). [S]

Plan of Treatment